Lukáš Vrba

1.1k citations
31 papers · 820 · h-index 19

Impact in

    • Cancer-related molecular mechanisms research
    • MicroRNA in disease regulation
    • Cancer Genomics and Diagnostics
  • Pharmacology top 10%
    • Hops Chemistry and Applications

Papers in

    • Epigenetics and DNA Methylation 12
    • RNA modifications and cancer 4
    • Cancer-related gene regulation 3
    • Cancer Genomics and Diagnostics 5
    • MicroRNA in disease regulation 5

Lukáš Vrba

31 papers receiving 803 citations

Peers

Lukáš Vrba
Comparison fields: 5 of 80
  • Cancer Research 301
  • Pharmacology 75
  • Molecular Biology 555
  • Oncology 135
  • Endocrinology 24
Replace Samir Acharya with:
Samir Acharya United States
Kristina Trenz Germany
Rusong Zhang China
Kamila Burdová Czechia
Xiangrong Cao China
Selvi Kunnimalaiyaan United States
Woo S. Joo United States
Bin Xue China
Steven W. Kohler United States
Walter Bardenheuer Germany
Lukáš Vrba relative to Samir Acharya United States Samir Acharya's profile →
Citations per field
00.5×
Samir Acharya · 1×
Citations per year

Countries citing papers authored by Lukáš Vrba

Since Specialization
Citations

This map shows the geographic impact of Lukáš Vrba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lukáš Vrba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lukáš Vrba more than expected).

Fields of papers citing papers by Lukáš Vrba

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lukáš Vrba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lukáš Vrba. The network helps show where Lukáš Vrba may publish in the future.

Co-authors

The 25 scholars most cited alongside Lukáš Vrba, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lukáš Vrba Line = papers co-authored together Lukáš Vrba links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2013110
2 201167
3 200857
4 201449
5 201749
6 200846
7 201535
8 201335
9 200132
10 200631
11 201430
12 201930
13 201529
14 200727
15 201524
16 199924
17 201224
18 200522
19 201719
20 200617

About Lukáš Vrba

Lukáš Vrba is a scholar working on Molecular Biology, Cancer Research, Plant Science, Oncology and Pharmacology, having authored 31 papers that have together received 820 indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (12 papers), Cancer Genomics and Diagnostics (5 papers), MicroRNA in disease regulation (5 papers), Hops Chemistry and Applications (5 papers), RNA modifications and cancer (4 papers), Cancer-related Molecular Pathways (3 papers), Cancer-related gene regulation (3 papers) and Plant Molecular Biology Research (3 papers). The work is most often cited by research in Cancer Research (301 citations), Pharmacology (75 citations), Molecular Biology (555 citations), Oncology (135 citations) and Endocrinology (24 citations). Lukáš Vrba has collaborated with scholars based in United States, Czechia and Germany. Frequent co-authors include Bernard W. Futscher, Martha R. Stampfer, James C. Garbe, José L. Muñoz-Rodríguez, Jaroslav Matoušek, Damian J. Junk, Josef Patzak, Paul Severson, Petr Novák and Marc M. Oshiro. Their work appears in journals such as Epigenetics, PLoS ONE, Journal of Agricultural and Food Chemistry, Cancer Research and Gene.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact